Issue 19, 2012

Nontoxic, nonvolatile, and highly efficient osmium catalysts for asymmetric dihydroxylation of alkenes and application to one mol-scale synthesis of an anticancer drug, camptothecin intermediate

Abstract

Novel polymer-incarcerated osmium (PI Os) catalysts have been developed. The Os catalysts were shown to be nontoxic and nonvolatile, and stable for several months in air. Asymmetric dihydroxylation of alkenes using these Os catalysts proceeded smoothly to afford the corresponding diols in high yields with high enantioselectivities. The catalysts could be recovered and reused. One mol-scale preparation of a key intermediate for camptothecin, an anticancer drug, has also been successfully demonstrated by using the catalysts.

Graphical abstract: Nontoxic, nonvolatile, and highly efficient osmium catalysts for asymmetric dihydroxylation of alkenes and application to one mol-scale synthesis of an anticancer drug, camptothecin intermediate

Supplementary files

Article information

Article type
Paper
Submitted
04 Jun 2012
Accepted
11 Jun 2012
First published
13 Jun 2012

RSC Adv., 2012,2, 7456-7461

Nontoxic, nonvolatile, and highly efficient osmium catalysts for asymmetric dihydroxylation of alkenes and application to one mol-scale synthesis of an anticancer drug, camptothecin intermediate

R. Akiyama, N. Matsuki, H. Nomura, H. Yoshida, T. Yoshida and S. Kobayashi, RSC Adv., 2012, 2, 7456 DOI: 10.1039/C2RA21123H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements